ytterbium (169yb) dtpa

Small moleculeapproved

Approved

Mar 11, 1976

Clinical trial activity

0 trials · 0 clinical orgs · 1 marketing orgs

Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0

Timeline

1970s

  1. Mar 11, 1976

    3M — Earliest FDA Approval

  2. Mar 11, 1976

    3M — NDA Secondary Org

  3. Mar 11, 1976

    3M — NDA Organization

Indications

Mechanism of action

  • DNADISRUPTING AGENT

    DNA disrupting agent

Approval history

  • approvedPriority reviewMar 11, 1976

Chemistry & pharmacology

Loading structure…

SMILES

O=C(O)CN(CCN(CC(=O)O)CC(=O)O)CCN(CC(=O)O)CC(=O)O.[Yb]
Mol. weight
666.29 g/mol
Chirality
Achiral Molecule
Inorganic
No
Polymer
No
Delivery
Parenteral
Availability
Discontinued
Payload
169-ytterbium

Oral

No

Parenteral

Yes

Topical

No

Sources

Also known as

  • pentetate calcium trisodium yb 169
  • pentetate calcium trisodium yb-169
  • pentetate calcium trisodium yb-169
  • ytterbium (169yb) dtpa
  • ytterbium pentetate
  • ytterbium yb 169 dtpa

Organizations

Marketing (2)

OrganizationOrg typeRelationshipDate
3MFor profitNDA2Mar 11, 1976
3MFor profitNDAMar 11, 1976